FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283711712> ?p ?o ?g. }

• W4283711712 endingPage "e068882" @default.
• W4283711712 startingPage "e068882" @default.
• W4283711712 abstract "To examine the association between dipeptidyl peptidase-4 inhibitors and gallbladder or biliary diseases.Systematic review and pairwise and network meta-analysis.PubMed, EMBASE, Web of Science, and CENTRAL from inception until 31 July 2021.Randomised controlled trials of adult patients with type 2 diabetes who received dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, and sodium-glucose cotransporter-2 inhibitors compared with placebo or other antidiabetes drugs.Composite of gallbladder or biliary diseases, cholecystitis, cholelithiasis, and biliary diseases.Two reviewers independently extracted the data and assessed the quality of the studies. The quality of the evidence for each outcome was assessed using the Grading of Recommendations, Assessment, Development and Evaluations framework (GRADE) approach. The meta-analysis used pooled odds ratios and 95% confidence intervals.A total of 82 randomised controlled trials with 104 833 participants were included in the pairwise meta-analysis. Compared with placebo or non-incretin drugs, dipeptidyl peptidase-4 inhibitors were significantly associated with an increased risk of the composite of gallbladder or biliary diseases (odds ratio 1.22 (95%confidence interval 1.04 to 1.43); risk difference 11 (2 to 21) more events per 10 000 person years) and cholecystitis (odds ratio 1.43 (1.14 to 1.79); risk difference 15 (5 to 27) more events per 10 000 person years) but not with the risk of cholelithiasis and biliary diseases. The associations tended to be observed in patients with a longer duration of dipeptidyl peptidase-4 inhibitor treatment. In the network meta-analysis of 184 trials, dipeptidyl peptidase-4 inhibitors increased the risk of the composite of gallbladder or biliary diseases and cholecystitis compared with sodium-glucose cotransporter-2 inhibitors but not compared with glucagon-like peptide-1 receptor agonists.Dipeptidyl peptidase-4 inhibitors increased the risk of cholecystitis in randomised controlled trials, especially with a longer treatment duration, which requires more attention from physicians in clinical practice.PROSPERO CRD42021271647." @default.
• W4283711712 created "2022-06-30" @default.
• W4283711712 creator A5000432967 @default.
• W4283711712 creator A5001800952 @default.
• W4283711712 creator A5003126503 @default.
• W4283711712 creator A5011666243 @default.
• W4283711712 creator A5044777415 @default.
• W4283711712 creator A5051075901 @default.
• W4283711712 creator A5061739018 @default.
• W4283711712 creator A5062254182 @default.
• W4283711712 creator A5063493594 @default.
• W4283711712 date "2022-06-28" @default.
• W4283711712 modified "2023-10-16" @default.
• W4283711712 title "Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials" @default.
• W4283711712 cites W1490158739 @default.
• W4283711712 cites W1495967812 @default.
• W4283711712 cites W1547857602 @default.
• W4283711712 cites W1617328014 @default.
• W4283711712 cites W1769745813 @default.
• W4283711712 cites W1911149840 @default.
• W4283711712 cites W1972215659 @default.
• W4283711712 cites W1973824615 @default.
• W4283711712 cites W1979638334 @default.
• W4283711712 cites W1981024765 @default.
• W4283711712 cites W1982202068 @default.
• W4283711712 cites W1995777506 @default.
• W4283711712 cites W1998735190 @default.
• W4283711712 cites W2018192866 @default.
• W4283711712 cites W2020827332 @default.
• W4283711712 cites W2033331104 @default.
• W4283711712 cites W2038270027 @default.
• W4283711712 cites W2038953694 @default.
• W4283711712 cites W2042751221 @default.
• W4283711712 cites W2045063167 @default.
• W4283711712 cites W2048728983 @default.
• W4283711712 cites W2051462052 @default.
• W4283711712 cites W2058569680 @default.
• W4283711712 cites W2059245135 @default.
• W4283711712 cites W2060537172 @default.
• W4283711712 cites W2061865937 @default.
• W4283711712 cites W2064130493 @default.
• W4283711712 cites W2073229674 @default.
• W4283711712 cites W2073787157 @default.
• W4283711712 cites W2084744936 @default.
• W4283711712 cites W2085803274 @default.
• W4283711712 cites W2092883481 @default.
• W4283711712 cites W2100987099 @default.
• W4283711712 cites W2103058881 @default.
• W4283711712 cites W2104288577 @default.
• W4283711712 cites W2109911153 @default.
• W4283711712 cites W2119981294 @default.
• W4283711712 cites W2121162069 @default.
• W4283711712 cites W2121796373 @default.
• W4283711712 cites W2126065052 @default.
• W4283711712 cites W2127854619 @default.
• W4283711712 cites W2128076015 @default.
• W4283711712 cites W2128243640 @default.
• W4283711712 cites W2128648250 @default.
• W4283711712 cites W2129578585 @default.
• W4283711712 cites W2134652590 @default.
• W4283711712 cites W2137069992 @default.
• W4283711712 cites W2138801798 @default.
• W4283711712 cites W2141946042 @default.
• W4283711712 cites W2142830692 @default.
• W4283711712 cites W2144193100 @default.
• W4283711712 cites W2144625636 @default.
• W4283711712 cites W2145335273 @default.
• W4283711712 cites W2150483909 @default.
• W4283711712 cites W2151668968 @default.
• W4283711712 cites W2153553370 @default.
• W4283711712 cites W2156098321 @default.
• W4283711712 cites W2157823046 @default.
• W4283711712 cites W2162969377 @default.
• W4283711712 cites W2165010366 @default.
• W4283711712 cites W2166173635 @default.
• W4283711712 cites W2168926920 @default.
• W4283711712 cites W2170952317 @default.
• W4283711712 cites W2171512247 @default.
• W4283711712 cites W2176264944 @default.
• W4283711712 cites W2181940024 @default.
• W4283711712 cites W2182241779 @default.
• W4283711712 cites W2202866687 @default.
• W4283711712 cites W2325963726 @default.
• W4283711712 cites W2344658675 @default.
• W4283711712 cites W2353007761 @default.
• W4283711712 cites W2416842703 @default.
• W4283711712 cites W246286872 @default.
• W4283711712 cites W2485875310 @default.
• W4283711712 cites W2498502918 @default.
• W4283711712 cites W2549339849 @default.
• W4283711712 cites W2560688864 @default.
• W4283711712 cites W2566584234 @default.
• W4283711712 cites W2592996796 @default.
• W4283711712 cites W2598893218 @default.
• W4283711712 cites W2608558167 @default.
• W4283711712 cites W2617902735 @default.
• W4283711712 cites W2619150022 @default.
• W4283711712 cites W2740741462 @default.

• next